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The current methods for the estimation of glomerular filtra-
tion rate (GFR) in small animals are limited by inaccuracy,
complexity and invasiveness [1, 21. To avoid the need for
constant infusion or urine collection and to improve accuracy,
techniques using a single intravenous injection of radioisotope
have been developed to estimate GFR [1—3]. The accuracy of
these techniques, however, is reduced by errors involving
isotope extravasation during tail vein injection and assumptions
about the volume of distribution required for the calculation of
GFR from a single blood sample [4]. Hence, to overcome these
problems we have developed and validated a simple non-
invasive technique employing a single intraperitoneal injection
of 99mTC diethylenetriaminepentaacetic acid (DTPA) and two
timed blood samples.
Methods
Male Wistar rats of a wide range of body weights, 250 to 650
g, were used in all experiments. They had free access to
standard rat chow and were not fasted prior to GFR studies.
Remnant kidneys were created by unilateral nephrectomy and
segmental infarction of the contralateral kidney under anaes-
thesia with ketamine (40 mg/kg)/xylazine (4 mg/kg). In a sepa-
rate group, nephrotic syndrome was induced by a single injec-
tion of doxorubicin (Adriamycin, 5 mg/kg, i.v.).
Technique
A measured, timed dose of approximately 20 MBq of 99mTc
DTPA (Pentatate II, Amersham international, UK) diluted in
0.2 rnls of isotonic saline was administered by intraperitoneal
(i.p.) injection, using an insulin syringe with a 26 gauge needle.
The residual activity retained in the syringe and the needle was
determined. A setback attachment was simply fashioned by
cutting off the end of a needle cap and attaching it to the needle
hub prior to injection. This allowed a 7 mm projection of the
needle which prevented administration of isotope into bowel or
fat. Two accurately timed heparinized blood samples of 200 p1
were taken from a tail vein approximately 45 and 90 minutes
later, under light anaesthesia with ether. After centrifugation,
two accurately measured 50 p1 aliquots of plasma (pipette
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inaccuracy 1%, Eppendorf, Hamburg, Germany) were trans-
ferred into 10 ml plastic counting tubes. mTc activity was
counted for 100 seconds by a sodium iodide crystal well counter
(LKB, Wallace 1280 Ultrogamma). GFR was calculated by
computer program using the slope-intercept method [4, 5],
incorporating background values, activity of a reference stan-
dard, measurement times and decay corrections (Appendix).
The pharmacokinetics of mTc DTPA after i.p. injection, in
the absence of renal excretion, was investigated by multiple
plasma samples for up to 100 minutes, in rats (N = 5) after
bilateral nephrectomy. The plasma time-disappearance curve of
i.p. 99mTc DTPA in normal rats (N 5) was estimated at 1, 2,
3, 4, 5 and 24 hours after injection to determine the period of
monoexponential kinetics necessary for accurate GFR estima-
tion. To assess constancy of GFR measurement within this
period, samples were drawn at '/2, 1, 1½, 2, 3 and 4 hours after
injection in normal rats (N = 5), and GFR was estimated from
two adjacent plasma samples.
The reproducibility of the method was assessed by four
alternate-day GFR estimations in normal rats (N = 6) and four
alternate-week estimations in rats (N = 18) with stable chronic
renal failure due to 5/6 nephrectomy.
The accuracy was determined by comparison of the method
to simultaneous 14C inulin clearance in normal (N = 12) and
partially nephrectomized (N = 12) rats over a wide range of
renal function and body weight. After rats had been anaesthe-
tised with 5-sec-butyl-ethyl-2-thiobarbituric acid (mactin, 100
to 120 mg/kg i.p.), the trachea was intubated for airway protec-
tion, the jugular vein and femoral artery were cannulated for
'4C inulin infusion and blood pressure estimation, respectively,
and the bladder was catheterized for urine collection under oil.
'4C-carboxylated inulin (Sigma) was dissolved in saline (0.125
Ci1ml) and administered at a loading volume of 1.5% body wt,
and thereafter at 1.5% body wt/hr. After a stabilization period
of 30 to 60 minutes, mTc DTPA was injected into the perito-
neal cavity. Its plasma clearance was calculated as described
above and compared to "C inulin clearance, estimated as the
mean Cn ivur consecutive, 20-minute urinary clearances. The
accuracy of the method was also determined by comparison to
simultaneous 14C inulin clearance in nephrotic rats (N =6)with
adriamycin nephrotoxicity. At two weeks these rats had severe
proteinuria (300 mgIlOO ml), hypoalbuminemia, lipemia, mildly
elevated plasma creatinine and ascites. No correction to either
GFR estimation was made for the reduction of measured
plasma activity caused by lipemia. In another subset of partially
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nephrectomized rats (N = 6) the sampling period was extended
to 45 and 150 minutes, and "Tc DTPA clearance was com-
pared to simultaneous '4C inulin clearance.
The activity of 14C inulin in plasma did not interfere with
99mTc activity measurements as its activity did not differ from
background when measured in the gamma counter. 99mTc
activity had decayed to background within three days, after
which 14C activity of 50 tl plasma and 10 p1 urine samples was
measured in duplicate for 300 seconds, in 5 ml of liquid
scintillant (Aquasol, NEN Research Products, Dupont, Boston,
Massachusetts, USA) by a liquid scintillation counter (LKB,
Wallace 1215 Rackbeta). Quench correction factors were deter-
mined for the addition of 10 1td urine and 50 pl plasma to
scintillant containing '4C inulin. mTc DTPA clearance from 45
to 90 minutes was also calculated using 99mTc activity in 10 p1
urine and 50 p1 plasma (Appendix).
99mTc DTPA clearance was calculated from the equation [5,
6]:
clearance (ml/min) = I x k/C0
where I is the injected activity (cpm), k is the exponential slope
of plasma clearance curve (min'), and C0 is zero time intercept
of plasma 99mTc DTPA clearance curve.
'4C inulin clearance and 99mTc DTPA clearance were also
calculated by:
clearance = U x V/P
where U is the urine activity of '4C or 99mTc (cpm), V is the
urine volume per unit time (ml/min), and P is the plasma activity
of 14C or 99mTc (cpm).
Statistics
The results have been expressed as mean standard error of
the mean (sEM), or confidence intervals (CI) as indicated. The
reproducibility of the method has been expressed as coefficient
of variation (CV). The comparisons of the method to inulin
clearance were made by linear regression analysis and exami-
nation of between-method differences to mean individual values
of both methods [7], using SPIDA (Statistical Package for
Interactive Data Analysis, Macquarie University Sydney, Aus-
tralia). Spearman rank correlation coefficients have also been
presented. P values below 0.05 were considered significant.
Results
When twenty MBq ofmTc DTPA was administered i.p. to
normal rats, a 50 1,d aliquot of plasma, taken 45 and 90 minutes
after injection, typically yielded 20,000 to 60,000 counts/minute
of mTc activity if measured in the gamma counter within six
hours. The rapid decay of 99mTc requires that plasma samples
be counted promptly (on the same day) in order to achieve
adequate counting precision. A radioactive counting precision
(standard deviation of measured activity) of better than 1% was
thus readily achieved. The injection technique resulted in 95.9
0.6% (N = 25) of the measured dose being administered, with
the remainder being accounted for as the dose residue.
After i.p. injection of 99mTc DTPA in rats with bilateral
nephrectomy, equilibrium with plasma was reached within 15 to
30 minutes, demonstrating a rapid distribution of isotope (Fig.
1). The plasma time-disappearance curves in normal rats dis-
played biexponential kinetics over 24 hours (Fig. 2), consistent
with a three compartment mammalian model [81. Within the
period 30 to 120 minutes after isotope injection, monoexponen-
tial kinetics were observed and sequential GFR estimations
were stable (CV = 4%) within that period. Hence 45 and 90
minutes were chosen as the optimal times for blood sampling of
rats with normal renal function. In partially nephrectomized
rats, the plasma time-disappearance slope was reduced and the
second phase clearance was less apparent. However, monoex-
ponential kinetics and constant GFR estimations were main-
tained for at least 180 minutes (CV = 6.5%; Fig. 3).
The reproducibility of the method was demonstrated by a
mean coefficient of variation in normal rats of 5.6 0.5% (N =
6). In partially nephrectomized rats with impaired but stable
renal function the mean CV was 7.4 1.2% (N = 18).
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Fig. 1. Equilibration to plasma of 99mTc DTPA, after intraperitoneal
injection of isotope in rats with bilateral nephrectomy (N = 5),
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Fig. 2. Time-disappearance of plasma 9'VTc DTPA, after intraperito-
neal injection of isotope in normal rats (N 5),
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The correlation of the method with simultaneo' '4C inulin
clearance was described by a line (y = I .02x + 0. ;, whose y
intercept included zero (95% CI = —0.13 to 0.19) and slope was
not significantly different from unity (95% CI = 0.95 to 1.10;
Fig. 4). Systematic bias was not observed in the differences
between the two methods (mean difference =
—0.07, SD = 0.20,
range —0.55 to 0.30, P < 0.001). The correlation was excellent
(r = 0.985, N = 24, P < 0.001) over a wide range of renal
function. In nephrotic rats with adriamycin nephrotoxicity, a
close correlation of the method with simultaneous inulin clear-
ance was observed (r = 0.89, N = 6), and was described by the
line: y = 0.97x — 0.06. When the sampling period was extended
to 150 minutes in partially nephrectomized rats, the correlation
with '4C inulin clearance was maintained (r = 0.84, N = 6). In
some rats with severely reduced renal function and reduced
plasma time-disappearance of uumTc DTPA, shortening the
sampling interval to less than the recommended 45 minutes
reduced the precision of GFR estimation. mTc DTPA clear-
ance calculated by urinary clearance also correlated closely
with inulin clearance (r = 0.95, N 16), as well as with the
plasma mTc DTPA method (r = 0.96, N = 16).
The measured plasma 99mTc activity had declined to back-
ground levels by 24 to 48 hours after injection in both normal
and partially nephrectomized rats. The efficiency of the method
was demonstrated by the fact that 15 rat GFR estimations,
including measurements and calculations, could be performed
in three hours. The procedure, which involved a single intra-
peritoneal injection and two short anaesthetics with ether for
blood sampling, was tolerated very well by the rats.
Discussion
The estimation of GFR by slope-intercept calculation follow-
ing intraperitoneal administration of 99mTc DTPA is an ideal
technique for use in experimental animals. It is simple, rapid,
reproducible, accurate and relatively non-invasive.
The traditional methods of estimating GFR include the mea-
surement of plasma creatinine, plasma urea, creatinine clear-
ance and urea clearance. While these methods are simple and
non-invasive, they are compromised as measurements of GFR
C14 Inulin clearance, mi/mm
Fig. 4. Comparison of GFR calculated by the intraperitoneal wTc
DTPA method with simultaneous '4C inulin clearance in normal ([=3)
and partially nephrecto,nized (•) rats. The fitted linear regression line
is described by the equation, y = 1.02x + 0.03, (r = 0.985, N = 24, P
<0.001).
by the lack of accuracy at low levels of renal function and by the
effect of body mass and dietary creatine intake [91. Although
inulin clearance is considered the gold standard for the mea-
surement of GFR in experimental animals, the procedure is
tedious and requires sacrifice of the animal. Moreover, GFR
measured over several hours by inulin clearance in an animal
subject to prolonged general anaesthesia, surgical trauma and
losses of body fluid, may not accurately reflect ambulatory
GFR.
Several methods employing single intravenous injection of
radioisotope have been developed to avoid the need for con-
stant infusion, urine collection and sacrifice [1—3]. However,
when these methods are used in small animals, the problems
encountered include the need for restraint for isotope adminis-
tration, the effects of anaesthesia and the error caused by
extravasation of the isotope when injected via the tail vein. This
latter problem can only be overcome reliably by direct cannu-
lation of a major blood vessel, such as the femoral vein. GFR
may then be calculated using either a slope-intercept method
which requires two timed blood samples, or the less accurate
single point estimation. The latter involves a set of reference
data and an assumption about the volume of distribution of the
isotope, which reduces the precision of estimates of GFR in
chronic renal failure and states of fluid retention [3, 4, 9, 10]. An
additional error may be introduced by variation in the optimal
time between injection and sampling, which increases as GFR
falls [9, 11, 12].
Intraperitoneal injection is a benchmark method of parenteral
administration in small animals. It is simple, easy, relatively
non-invasive and does not require anaesthesia, thus resulting in
minimal perturbation of the experimental animal. The rapid
equilibration of i.p. 99mTC DTPA to plasma makes it suitable for
estimation of GFR. By the use of two timed blood samples,
assumptions about volume of distribution, which are implicit in
the single sample method, may be avoided and thus accuracy
maximized [9, 11, 12]. The accuracy of this method is demon-
strated by its close correlation with simultaneous inulin clear-
ance, which is maintained over a wide range of renal function
and body weight, in normal, uremic and nephrotic rats. The rate
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Fig. 3. Time-disappearance of plasma '"Tc DTPA, after intraperito-
neal injection of isotope in normal +, (N = 5) and partially nephrec-
tomized, (N = 4) rats (mean SEM).
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of renal clearance of 99mTc DTPA is unaffected by varying urine
flow rates or by the administration of probenecid [13], which
excludes a major capacity for tubular processing of DTPA [6,
13]. The short half life of 99mTc of six hours (compared to that
of 51Cr EDTA of 28 days) allows the technique to be repeated at
one to two day intervals, even in rats with substantially reduced
renal function. Because it is minimally invasive, results ob-
tained by this technique reflect ambulatory GFR.
The efficiency, reproducibility, accuracy and relatively non-
invasive nature of the intraperitoneal mTc DTPA method
makes it ideal for repeated measurements of GFR in large
numbers of small experimental animals.
Acknowledgments
Portions of this work were presented at the 27th Annual Scientific
Meeting of the Australian and New Zealand Society of Nephrology,
March 1991, Christchurch, NZ. BJN is in receipt of a National Health
and Medical Council postgraduate research scholarship. The work was
also supported by a Grant-in-Aid from the Australian Kidney Founda-
tion and the Government Employees Assistance to Medical Research
Fund. The authors would like to thank Dr. K. Byth for statistical advice
and Mrs. R. Hunt for secretarial assistance.
Reprint requests to Dr. B.J. Nankivell, Department of Renal Medi-
cine, Westmead Hospital, Westmead, 2145, NSW, Australia.
References
1. BRYAN CW, JARCHOW RC, MAHER JF: Measurement of glomerular
filtration rate in small animals without urine collection. J Lab Glitz
Med 80:845—846, 1972
2. LAYZELL D, MILLER T: Determination of glomerular filtration in
the rat using 51Cr-EDTA and a single blood sample. Invest Urol
13:200—204, 1975
3. HALL JE, GUYTON AC, FARR BM: A single injection method for
measuring glomerular filtration rate. Am J Physiol 232:F72—F76,
1977
4. O'REILLY PH, SHIELDS RA, TE5TA HJ: Nuclear Medicine in
Urology and Nephrology. London, Butterworths, 1979, p. 25
5. FAWDRY RM, GRUENEWALD SM, COLLINS LT, ROBERTS AJ:
Comparative assessment of techniques for investigation of glomer-
ular filtration rate with mTcDTPA, Ear J Nuci Med 11:7—12, 1985
6. PETERS AM: Quantification of renal haemodynamics with radionu-
clides. Ear J Nucl Med 18:274—286, 1991
7. BLAND JM, ALTMAN DG: Statistical methods for assessing agree-
nient between two methods of clinical measurement. Lancet i:307—
310, 1986
8. COHEN ML: Radionuclide clearance techniques. Semin Nucl Med
4:22—38, 1974
9. TAUXE WN: Nuclear Medicine in Clinical Urology and Nephro!-
ogy. Norwalk, Appleton-Century-Crofts, 1985, p. 61
10. HARVEY JN, JAFFA AA, LOADHOLT CB, MAYFIELD RK: Measure-
ment of glomerular filtration rate and renal plasma flow in the
diabetic rat by the single injection isotope technique: Effects of
altered distribution volume of 5tCr-EDTA and 25I-hippuran. Dia-
betes Res 9:67—72, 1988
11. SMART R, TREW P, BURKE J, LYONS N: Simplified estimation of
glomerular filtration rate and effective renal plasma flow. Eur J
NucI Med 6:249—253, 1981
12. RU5SEL CD, BI5cR0FF PG, KONTZEN FN, ROWELL KL, YESTER
MV, LLOYD LK, TAUXE WN, DUBOVSKY EV: Measurement of
glomerular filtration rate: Single injection plasma clearance method
without urine collection. J NucI Med 26:1243—1247, 1985
13. KLOPPERJF, HAUSER W, ATKINS HL, ECKELMAN WC, RICHARDS:
Evaluation of "TcDTPA for the measurement of glomerular
filtration rate. JNuc Med 13:107—1 10, 1972
Appendix
Abridged from references No. 4, 5 and 6
1. The Classical Method for the estimation of glomerular
filtration rate is the measurement of the rate of appearance of a
test substance (for example, inulin) in the urine over a specified
time interval after establishing and maintaining constant plasma
concentration using continuous i.v. infusion. Then the renal
clearance is given by:
Clearance = UV/P
where U is the concentration of the test substance in the urine,
P is the concentration of the test substance in the plasma and V
is the urine flow rate during the test period. If the test substance
is filtered at the glomerulus as efficiently as water, then the
clearance is a measurement of the glomerular filtration rate
(GFR).
2. Single injection of tracer with urine and nlasma sampling.
After a single injection of a GFR tracer, the plasma concen-
tration will vary continuously with time, so that the clearance
equation now only applies for a short time interval, M, during
which the plasma concentration, P, is reasonably constant.
During this short time interval the portion of the urine volume
produced is V and has tracer concentration U, as before. Then
UVClearance = P&
Integrating the numerator (physically) and the denominator
mathematically gives:
UVClearance =
ft2
tIJ
Pdt
where V is the total urine volume produced during the sampling
interval from times tl to t2.
3. Single injection of tracer with only plasma sampling.
By considering the entire "infinite" time interval from injec-
tion onwards and assuming that all of the tracer is eventually
excreted and only via the renal route then the total quantity of
tracer excreted (UV) will be equal to the injected dose (I).
Hence:
IClearance =
of Pdt
If one assumes that monoexponential kinetics are an acceptable
description of plasma concentration versus time (that is, P =
Ce_kt) then
1kClearance =
Co
where I is the net injected dose, k the exponential slope of
plasma clearance curve, and C0 is the zero time intercept of
plasma clearance curve.
Protocol
The activities of a standard dose and the dose administered to
the animal (20 MBq mTc each) are measured in an ion
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chamber dose calibrator noting activity and time. The standard
is diluted to 1000.0 ml in a volumetric flask and the time of
animal injection recorded. The syringe residues for the standard
and animal dose are measured and the time recorded.
All activities are then corrected for decay from a common
time, such as the injection time, using
A0 = Aet)
where A0 is the activity corrected for decay from injection time,
A is measured activity, A = 1n2 /T½ where T'/2 for mTc is 6.02
hours, and zIt is the measurement time — injection time.
Then for both the standard and animal dose;
Net dose = (decay corrected dose)
— (decay corrected residue)
Aliquots of the diluted standard and the two plasma samples (50
d each) and background are counted in the scintillation well
counter and the net count rate (for standard or plasma) is
obtained by subtraction of the background count rate.
The injected activity (I) is given by:
(Net standard count rate) x (net animal dose) x 1000 (for dilution)
and
Net standard dose
1k
GFR (50 p11mm) =
CO
or in more conventional units
501k
GFR (mi/mm) =
1000 C0
where I is the injected activity (cpm), k is the exponential slope
of plasma clearance (min I), and C0 is the zero time intercept of
plasma clearance curve (cpm/50 .d) (derived by extrapolation of
plasma clearance curve).
